However, other studies suggest that LysoPC levels are reduced in patients with impaired fasting glucose, T2D, and in animal models of obesity and insulin resistance, indicating that LysoPC may increase GLUT4 expression on adipocyte membranes, enhancing glucose uptake and improving glucose metabolism [18]. The gene discussed is SLC2A4; the disease is obesity disorder.